Drugs / Urinary Kallidinogenase
last change Jun 2026 re-read 3 minutes ago

Urinary Kallidinogenase

Developed for
ischemic stroke · type 2 diabetes mellitus
Investigated by
First Affiliated Hospital, Sun Yat-Sen University · Yi Yang

Trials 2

PhaseRegistry idDatesIndicationSponsorStatusOutcome
— NCT06137300 Mar 2024 → Jun 2026 overdue ischemic stroke Yi Yang Not yet recruiting No outcome recorded
— NCT06085378 Jan 2024 → Dec 2026 expected ischemic stroke, type 2 diabetes mellitus First Affiliated Hospital, Sun Yat-Sen University Not yet recruiting No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as Urinary Kallidinogenase ClinicalTrials.gov intervention name — accepted as the source's own label NCT06085378 ↗
1

NCT06137300 ↗